HansBiomed Corporation (042520.KQ) stock: key figures, P/E, revenue and dividend

Health Care · Biotechnology · South Korea · ISIN KR7042520007

Price
16,980.00 KRW
Market cap
220.52 bn KRW
P/E (2025)
–
P/S (2025)
2.46
Dividend yield
0.00 %
Net margin
-34.91 %
Return on equity (ROE)
-92.99 %
Return on assets (ROA)
-24.79 %

HansBiomed Corporation financials

Fiscal year20242025
Revenue81.14 bn KRW89.78 bn KRW
Gross profit51.75 bn KRW51.51 bn KRW
Operating income630.00 m KRW-25.89 bn KRW
EBIT-4.86 bn KRW-27.92 bn KRW
Net income-7.22 bn KRW-31.34 bn KRW
Diluted EPS – continuing operations-556.17 KRW-2,413.29 KRW

Full history since 2012, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About HansBiomed Corporation

HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. The company provides ExFuse, a demineralized bone matrix with cancellous bone gel/putty; BellaFuse, a demineralized bone matrix; Genesis, a cancellous sponge block/filler; Pedi-Stick, a demineralized cortical bone stick; SureChip, a cancellous bone chip; OsteoGrow, a demineralized bone matrix inserter; BellaCell HD, an allograft dermal product that transplanted in a patient whose skin has been lost due to breast cancer; and SureDerm, an acellular dermal matrix. It also offers BELLAGEL, a breast prosthesis, internal, and gel-filled solution; MINT Lift, a PDO thread; EZ-Tcon solution; Lion HT/HN, a hair transplanter body/needle; and Scar Clinic, a scar management solution. The company was formerly known as Hans Medical Corp. and changed its name to HansBiomed Corporation in June 2000. The company was founded in 1990 and is headquartered in Seoul, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.